Clinical Trials
26 trialsA Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors
BeOne Medicines
A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors
LARKSPUR BIOSCIENCES, INC.
A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors
BeOne Medicines
BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors
BeOne Medicines
SABR-SYNC
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Cryopreservation of Ovarian Tissue
Weill Medical College of Cornell University
SABR-COMET 10
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China
RenJi Hospital
IO-001
iTeos Therapeutics
Effects of Chemotherapy on Perceived Daily Performance and Executive Functions of Adults With Cancer
Bnai Zion Medical Center
RENMIN-213
Renmin Hospital of Wuhan University
Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma
Jiangsu Cancer Institute & Hospital
Clinical Observation of Integrated Chinese Medicine With Western Medicine for the Reduction of Chemotherapy-induced Hematologic Toxicity
Taichung Tzu Chi Hospital
Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary
Shanghai Changzheng Hospital
Treatment of High-Risk Cerebral Primitive Neuroectodermal Tumors in Children Aged Over 5 Years
Gustave Roussy, Cancer Campus, Grand Paris
Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
Haining Health-Coming Biotech Co., Ltd.
Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma
Oncolytics Biotech
ECLIPSE
Aduro Biotech, Inc.
Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy
Yonsei University
Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Low Dose Chemotherapy Versus Best Supportive Care in Progressive Pediatric Malignancies
All India Institute of Medical Sciences
Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation
Chinese PLA General Hospital
Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma
University of Utah
p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage
Shenzhen SiBiono GeneTech Co.,Ltd
rAd-p53
Shenzhen SiBiono GeneTech Co.,Ltd